1. Cinepazide-related agranulocytosis

   Newsletter Article 27 January 2013 Pages: 1 - 1

2. A prospective trial of the adverse effects of clozapine

   Newsletter Article 27 January 2013 Pages: 1 - 1

3. Consider propranolol in the diagnosis of depression

   Newsletter Article 27 January 2013 Pages: 1 - 1

4. Drug toxicity associated with the use of antirheumatic medication

   Newsletter Article 27 January 2013 Pages: 2 - 2

5. Amphotericin B

   Newsletter Article 27 January 2013 Pages: 3 - 4

6. Anabolic steroids

   Newsletter Article 27 January 2013 Pages: 4 - 4

7. Aztreonam

   Newsletter Article 27 January 2013 Pages: 4 - 4

8. Bendroflumethiazide

   Newsletter Article 27 January 2013 Pages: 4 - 4

9. Benzyl benzoate

   Newsletter Article 27 January 2013 Pages: 4 - 4

10. Betaxolol/carteolol/timolol

    Newsletter Article 27 January 2013 Pages: 4 - 4

11. Bleomycin see Cisplatin/vinblastine/bleomycin

    Newsletter Article 27 January 2013 Pages: 4 - 4

12. Busulfan

    Newsletter Article 27 January 2013 Pages: 4 - 4

13. Captopril/enalapril

    Newsletter Article 27 January 2013 Pages: 4 - 5

14. Captopril/methyldopa/propranolol

    Newsletter Article 27 January 2013 Pages: 5 - 5

15. Carteolol see Betaxolol/carteolol/timolol

    Newsletter Article 27 January 2013 Pages: 5 - 5

16. Cisplatin/vinblastine/bleomycin

    Newsletter Article 27 January 2013 Pages: 5 - 5

17. Dactinomycin

    Newsletter Article 27 January 2013 Pages: 5 - 5

18. Dexamethasone

    Newsletter Article 27 January 2013 Pages: 5 - 5

19. Dexamethasone see Prednisone/dexamethasone

    Newsletter Article 27 January 2013 Pages: 5 - 5

20. Enalapril see Captopril/enalapril

    Newsletter Article 27 January 2013 Pages: 5 - 5

21. Enalapril

    Newsletter Article 27 January 2013 Pages: 6 - 6

22. Enoxaparin/low molecular weight heparin

    Newsletter Article 27 January 2013 Pages: 6 - 6

23. Erythromycin

    Newsletter Article 27 January 2013 Pages: 6 - 6

24. Heparin

    Newsletter Article 27 January 2013 Pages: 6 - 6

25. Hydrochlorothiazide

    Newsletter Article 27 January 2013 Pages: 6 - 6

26. Hydrochlorothiazide see Triamterene + hydrochlorothiazide

    Newsletter Article 27 January 2013 Pages: 6 - 6

27. Hydroxycarbamide

    Newsletter Article 27 January 2013 Pages: 6 - 6

28. Interleukin 2

    Newsletter Article 27 January 2013 Pages: 6 - 6

29. Interleukin 2 ± lymphokineactivated killer cells

    Newsletter Article 27 January 2013 Pages: 6 - 6

30. Iopamidol

    Newsletter Article 27 January 2013 Pages: 6 - 7

31. Lymphokine-activated killer cells see Interleukin 2 ± lymphokineactivated killer cells

    Newsletter Article 27 January 2013 Pages: 7 - 7

32. Methyldopa see Captopril/methyldopa/propranolol

    Newsletter Article 27 January 2013 Pages: 7 - 7

33. Prednisone

    Newsletter Article 27 January 2013 Pages: 7 - 7

34. Prednisone/dexamethasone

    Newsletter Article 27 January 2013 Pages: 7 - 7

35. Propranolol see Captopril/methyldopa/propranolol

    Newsletter Article 27 January 2013 Pages: 7 - 7

36. Timolol see Betaxolol/carteolol/timolol

    Newsletter Article 27 January 2013 Pages: 7 - 7

37. Timolol

    Newsletter Article 27 January 2013 Pages: 7 - 7

38. Triamterene + hydrochlorothiazide

    Newsletter Article 27 January 2013 Pages: 7 - 7

39. Trimethoprim

    Newsletter Article 27 January 2013 Pages: 7 - 8

40. Valproic acid

    Newsletter Article 27 January 2013 Pages: 8 - 8

41. Valproic acid poisoning

    Newsletter Article 27 January 2013 Pages: 8 - 8

42. Vancomycin

    Newsletter Article 27 January 2013 Pages: 8 - 8

43. Vigabatrin

    Newsletter Article 27 January 2013 Pages: 8 - 8

44. Vinblastine see Cisplatin/vinblastine/bleomycin

    Newsletter Article 27 January 2013 Pages: 8 - 8

45. Yohimbine

    Newsletter Article 27 January 2013 Pages: 8 - 8